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Background: In angiographically intermediate left main coronary artery (LMCA) lesions a minimum lumen area (MLA) of 6 mm2 has been 
proposed as a cut-off value. There are not studies evaluating the prospective application and safety of this approach in a long term follow up.
Methods: We have designed a multicentered prospective study in order to evaluate the long term results of the prospective application of 6 mm2 
as a MLA IVUS derived criterion for intermediate lesions in the LMCA. We included patients showing intermediate (25-50%) non-complicated lesions 
in unprotected LMCA and without surgical indications based in other lesions. LMCA revascularization was indicated when MLA < 6mm2. IVUS studies 
were reviewed in a core lab.
Results: During 2007 a total of 331 patients were included in 22 centers. In 179 pts MLA was ≥ 6 mm2 and no revascularization of LMCA 
was done (DEF group), though 55.3% of them had PCI in other lesions. The remaining 152 with MLA< 6mm2 were revascularized (REV group) 
with PCI (44.7%) or CABG (55.3%). Clinical data in the DEF group were: age 66.5 ±11 yrs, 35.7% diabetic, 29.6% previous MI, 32.4% previous 
revascularization and 47.4% had ACS. No significant differences were observed with the REV group. Regarding angiographic measurements, pts in 
DEF group showed less stenosis (36±9% vs 40±10%; p=0.002), larger minimum lumen diameter (2.5±0.6 vs 2.3±07mm;p=0.005) but significant 
overlapping existed between both groups. IVUS parameters in DEF group were MLA 9.3± 3 mm2 (in 40% < 8mm2) and plaque burden 53 ±12% 
and in REV group 4.8±0.8 mm2 and 67 ±11% (p<0.001 between groups). At 2 years in DEF group survival free from cardiac death and infarction 
was 98.1% (93.4% in REV group, p=0.04), survival free from LMCA revascularization 99.3% and survival free from cardiac death, infarction and any 
revascularization 92.4%.
Conclusion: Assessment of LMCA intermediate non-complicated lesions by IVUS using the cut-off value of MLA ≥ 6 mm2 for deferring LMCA 
revascularization results to be safe in periods up to 2 years.
